ClinicalTrials.Veeva

Menu

Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography

George Washington University (GW) logo

George Washington University (GW)

Status

Terminated

Conditions

Breast Cancer

Treatments

Device: SureTouch

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT04397029
GW10029

Details and patient eligibility

About

Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Full description

This is a single-center, prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.

Results of the mammography will be compared to the SureTouch examination results.

Subjects will have between 1 and 3 research visits and 3 follow-up surveys, up to two years from the initial visit. The number of visits will be based upon comparison of the SureTouch examination to conventional breast screening techniques (mammogram and ultrasound).

Enrollment

213 patients

Sex

Female

Ages

30 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Arm 1:

  • Female Subject presenting for screening mammography
  • 30-80 years of age, inclusive
  • Able to provide written informed consent

Arm 2:

  • Female Subject presenting for diagnostic appointment and/or biopsy
  • 30-80 years of age, inclusive
  • 1-3 masses per breast
  • Masses between 0.5 cm and 3.5 cm only

Exclusion criteria

  • Individuals who are unable to comprehend or unwilling to sign an informed consent form
  • Women younger than 30 or older than 80
  • Pregnant women
  • Women who have undergone bilateral mastectomies
  • Males
  • Prisoners
  • Masses which are larger than 3.5 cm or smaller than 0.5 cm in size
  • Individuals with more than 3 masses per breast will be excluded due to the complexity of these cases

Trial design

Primary purpose

Screening

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

213 participants in 2 patient groups

Subjects without messes
Experimental group
Description:
Subjects who are believed to be free of masses.
Treatment:
Device: SureTouch
Subjects with known masses
Experimental group
Description:
Subjects with known masses.
Treatment:
Device: SureTouch

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems